The new vaccine is the first to attack the “tangles” of protein that are found in the brains of patients with Alzheimer's and some other types of dementia.
ASS234 is a promising multitarget molecule due to its potential therapeutic effects on patients with Alzheimer's disease.
Las opiniones vertidas por nuestros colaboradores se realizan a nivel personal, pudiendo coincidir o no con la postura de la dirección de Protestante Digital.
